background image

Melanoma Clinical Trials

Find clinical trials for melanoma. Search for melanoma clinical trials in different cities and states across the United States.

Filter
1

Iron & Immunotherapy

Recruiting
PHASE2

Sponsor:

Indiana University

Location:

Indianapolis IN

Code:

NCT06508827

Conditions

Anemia, Iron Deficiency

Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Iron dextran 1000 mg IV

HLA Testing

Recruiting

Sponsor:

TScan Therapeutics, Inc.

Location:

Scottsdale AZ, San Diego CA, New Haven CT, Hollywood FLshow 13 more

Code:

NCT05812027

Conditions

Head and Neck Cancer

Cervical Cancer

Non Small Cell Lung Cancer

Melanoma

Ovarian Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tumor and HLA Profiling

Influenza Vaccine

Recruiting
PHASE1

Sponsor:

Carlo Contreras

Location:

Columbus OH

Code:

NCT04697576

Conditions

Clinical Stage I Cutaneous Melanoma AJCC V8

Clinical Stage IA Cutaneous Melanoma AJCC V8

Clinical Stage IB Cutaneous Melanoma AJCC V8

Clinical Stage II Cutaneous Melanoma AJCC V8

Clinical Stage IIA Cutaneous Melanoma AJCC V8

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Ipilimumab

Nivolumab

Pembrolizumab

Quadrivalent Inactivated Influenza Vaccine

Resection

SX-682 with Pembrolizumab

Recruiting
PHASE1

Sponsor:

Syntrix Biosystems, Inc.

Location:

Miami FL, Boston MA, Rochester MN, Rochester NYshow 1 more

Code:

NCT03161431

Conditions

Melanoma Stage III

Melanoma Stage IV

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

SX-682

Pembrolizumab

AlpeliSib & PEmbroLizumab

Recruiting
PHASE1
PHASE2

Sponsor:

M.D. Anderson Cancer Center

Location:

Houston TX

Code:

NCT06545682

Conditions

Myelodysplastic Syndrome(MDS)

Acute Myelogenous Leukemia (AML)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Alpelisib + Pembrolizumab

AB248 & Pembrolizumab

Recruiting
PHASE1

Sponsor:

Asher Biotherapeutics, Inc.

Location:

Duarte CA, Los Angeles CA, San Diego CA, San Francisco CAshow 14 more

Code:

NCT05653882

Conditions

Solid Tumor

Non Small Cell Lung Cancer

Melanoma

Squamous Cell Carcinoma of Head and Neck

Renal Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

etakafusp alfa (AB248)

pembrolizumab

Avapritinib

Recruiting
PHASE2

Sponsor:

M.D. Anderson Cancer Center

Location:

Houston TX

Code:

NCT04771520

Conditions

Anatomic Stage IV Breast Cancer AJCC v8

Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8

Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8

Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8

Locally Advanced Malignant Solid Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Avapritinib

IK-595

Recruiting
PHASE1

Sponsor:

Ikena Oncology

Location:

Duarte CA, Orange CA, Denver CO, Washington DCshow 11 more

Code:

NCT06270082

Conditions

Solid Tumor, Adult

Colorectal Cancer

Pancreatic Cancer

Malignant Melanoma

Ras (Kras or Nras) Gene Mutation

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

IK-595

Radiotherapy & Immunotherapy

Recruiting
PHASE2

Sponsor:

M.D. Anderson Cancer Center

Location:

Houston TX

Code:

NCT05546827

Conditions

Sinonasal Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Surgical resection

[225Ac]-FPI-1434

Recruiting
PHASE1
PHASE2

Sponsor:

Fusion Pharmaceuticals Inc.

Location:

Duarte CA, Boston MA, Minneapolis MN, Buffalo NYshow 7 more

Code:

NCT03746431

Conditions

Advanced Solid Tumours

Endometrial Cancer

Cervical Cancer

Ovarian Cancer

Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

[111In]-FPI-1547 Injection

[225Ac]-FPI-1434 Injection multi-dose

FPI-1175 Infusion

[225Ac]-FPI-1434 Injection single-dose